GSK plc
GSK's GHG Emissions Data Preview
In 2024, GSK completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, GSK has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind GSK’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore GSK’s data sources below and access millions more through our Disclosure Search.
Insights into GSK's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of GSK amounted to 755,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of GSK decreased by 8.04%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
GSK's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are GSK's Scope 1 emissions?
In 2024, the total Scope 1 emissions of GSK were 521,000 metric tons of CO₂ equivalent (tCO₂e). a
Has GSK reduced its Scope 1 emissions over time?
Since 2020, GSK's Scope 1 emissions have decreased by 26.72%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), GSK's Scope 1 emissions decreased by 10.33%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are GSK's Scope 2 emissions?
In 2024, GSK reported Scope 2 greenhouse gas (GHG) emissions of 44,000 tCO₂e using the market-based method and 234,000 tCO₂e using the location-based method. a
Has GSK reduced its Scope 2 emissions over time?
Since 2020, GSK's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have decreased by 24.27%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2023), GSK's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that GSK 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does GSK use for Scope 2 reporting?
In 2024, GSK reported its Scope 2 emissions using the market-based method and using the location-based method. a
GSK's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into GSK’s GHG Emissions Intensity Compared to Industry Peers
In 2024, GSK reported Scope 1 greenhouse gas (GHG) emissions of 521,000 tCO₂e and total revenues of USD 39,374 millions. This translates into an emissions intensity of 13.23 tCO₂e per millions USD. a
GSK's Scope 1 Emissions Intensity Compared to Peers
How does GSK's GHG emissions intensity compare to its peers?
In 2024, GSK reported a Scope 1 emissions intensity of 13.23 tCO₂e per millions USD. Compared to the peer group median of 5.34 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does GSK rank on GHG emissions intensity within its industry?
In 2024, GSK ranked 20 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
GSK is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a